Clinical trial
Clinical Trial of High Dose CoQ10 in ALS
NCT00243932 · Columbia University, Other · Completed
Key facts
| NCT number | NCT00243932 |
|---|---|
| Title | Clinical Trial of High Dose CoQ10 in ALS |
| Official title | Clinical Trial of High Dose CoQ10 in ALS |
| Lead sponsor | Columbia University, Other |
| Collaborators | National Institute of Neurological Disorders and Stroke (NINDS) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amyotrophic Lateral Sclerosis, Lou Gehrig's Disease |
| Intervention type | Drug |
| Interventions | coenzyme Q10, Placebo |
| Enrollment | 185 |
| Start date | Apr 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Oct 25, 2005 |
| Last update posted | May 7, 2024 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: